TW200510542A - Equol-producing lactic acid bacteria-containing composition - Google Patents

Equol-producing lactic acid bacteria-containing composition

Info

Publication number
TW200510542A
TW200510542A TW093119028A TW93119028A TW200510542A TW 200510542 A TW200510542 A TW 200510542A TW 093119028 A TW093119028 A TW 093119028A TW 93119028 A TW93119028 A TW 93119028A TW 200510542 A TW200510542 A TW 200510542A
Authority
TW
Taiwan
Prior art keywords
equol
lactic acid
acid bacteria
containing composition
producing lactic
Prior art date
Application number
TW093119028A
Other languages
English (en)
Other versions
TWI335353B (en
Inventor
Shigeto Uchiyama
Tomomi Ueno
Toshimi Suzuki
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of TW200510542A publication Critical patent/TW200510542A/zh
Application granted granted Critical
Publication of TWI335353B publication Critical patent/TWI335353B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
    • A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
    • A23C11/106—Addition of, or treatment with, microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/60—Drinks from legumes, e.g. lupine drinks
    • A23L11/65—Soy drinks
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
TW093119028A 2003-06-30 2004-06-29 Equol-producing lactic acid bacteria-containing composition TWI335353B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003187831 2003-06-30

Publications (2)

Publication Number Publication Date
TW200510542A true TW200510542A (en) 2005-03-16
TWI335353B TWI335353B (en) 2011-01-01

Family

ID=33549734

Family Applications (2)

Application Number Title Priority Date Filing Date
TW093119028A TWI335353B (en) 2003-06-30 2004-06-29 Equol-producing lactic acid bacteria-containing composition
TW099134382A TW201118175A (en) 2003-06-30 2004-06-29 Equol-producing lactic acid bacteria-containing composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW099134382A TW201118175A (en) 2003-06-30 2004-06-29 Equol-producing lactic acid bacteria-containing composition

Country Status (22)

Country Link
US (3) US8765445B2 (zh)
EP (2) EP2548455B1 (zh)
JP (1) JP3864317B2 (zh)
KR (2) KR101043465B1 (zh)
CN (1) CN1826059B (zh)
AR (1) AR044953A1 (zh)
AU (1) AU2004251563B2 (zh)
BR (1) BRPI0412180B1 (zh)
CA (1) CA2531173C (zh)
CY (2) CY1114248T1 (zh)
DK (2) DK2548455T3 (zh)
ES (2) ES2417481T3 (zh)
HK (1) HK1090812A1 (zh)
HU (1) HUE030615T2 (zh)
MX (1) MXPA06000074A (zh)
MY (1) MY146563A (zh)
PL (2) PL2548455T3 (zh)
PT (2) PT1649760E (zh)
SG (1) SG157232A1 (zh)
SI (2) SI2548455T1 (zh)
TW (2) TWI335353B (zh)
WO (1) WO2005000042A1 (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI473572B (zh) * 2007-06-13 2015-02-21 大塚製藥股份有限公司 An extract containing equol (EQUOL), a method for producing the same, an equol extraction method and an equol-containing food
TWI491732B (zh) * 2005-12-06 2015-07-11 Otsuka Pharma Co Ltd 含雌馬酚（ｅｑｕｏｌ）之大豆胚軸發酵物及其製造方法

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06000074A (es) * 2003-06-30 2006-03-21 Otsuka Pharma Co Ltd Composicion que contiene bacterias de acido lactico que producen equol.
JP4811760B2 (ja) * 2004-12-27 2011-11-09 独立行政法人農業・食品産業技術総合研究機構 ダイゼイン資化によるエコール生成能を改善するための腸内細菌およびその利用
US9080197B2 (en) 2005-11-02 2015-07-14 Kabushiki Kaisha Yakult Honsha Equol level regulator
JP2007308428A (ja) * 2006-05-19 2007-11-29 Fancl Corp 摂食抑制剤
JP5122766B2 (ja) * 2006-06-20 2013-01-16 ユニチカ株式会社 エコール産生促進組成物
JP5517613B2 (ja) * 2007-05-28 2014-06-11 不二製油株式会社 エクオール非産生者用の血中エクオール産生促進組成物
AU2013203101B2 (en) * 2007-06-13 2015-07-09 Otsuka Pharmaceutical Co., Ltd. Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food
WO2009065722A1 (en) * 2007-11-23 2009-05-28 Unilever Nv Fermented soy-based beverage
PT2228441E (pt) * 2007-12-27 2013-08-27 Otsuka Pharma Co Ltd Enzima envolvida na síntese de equol
JP2009232712A (ja) * 2008-03-26 2009-10-15 Glico Dairy Products Co Ltd エクオール産生組成物，エクオール産生方法及びエクオール含有組成物
KR101600867B1 (ko) * 2008-06-03 2016-03-10 삼성전자주식회사 냉장고
EP3563689B1 (en) 2008-09-19 2021-12-15 Otsuka Pharmaceutical Co., Ltd. Method for producing a fermentation product containing equol-produing microorganism having maintained equol-producing ability
AU2014240200B2 (en) * 2008-09-19 2015-08-13 Otsuka Pharmaceutical Co., Ltd. Fermentation product containing equol-producing microorganism having maintained equol-producing ability, and method for producing same
ES2641604T3 (es) * 2009-02-25 2017-11-10 Kabushiki Kaisha Yakult Honsha Bacteria productora de equol y uso de la misma
JP2011036190A (ja) * 2009-08-12 2011-02-24 Enseki Aojiru Kk 顆粒状経口食品の製造方法及びその顆粒状経口食品
JP5777287B2 (ja) * 2009-09-18 2015-09-09 大塚製薬株式会社 エクオール産生能が維持されたエクオール産生微生物を含む発酵製品、及びその製造方法
KR101024297B1 (ko) * 2010-08-11 2011-03-29 유익종 유산 발효에 의해 계란단백질의 항원성이 저하된 유산발효계란 및 그의 제조방법
CN102021130A (zh) * 2010-10-21 2011-04-20 南京农业大学 一株降解大豆苷原产生雌马酚的双酶梭菌及其菌剂和应用
US20120251511A1 (en) * 2011-03-28 2012-10-04 Eric Donald Murphy Composition and products for enabling the production of equol in vivo
NL2008294C2 (en) * 2011-05-20 2013-08-19 Friesland Brands Bv Food composition comprising vitamin k and saturated fat.
ITMI20111829A1 (it) * 2011-10-07 2013-04-08 Paladin Pharma S P A Procedimento per la preparazione di una composizione a base di equolo
KR101307947B1 (ko) 2011-11-30 2013-09-12 씨제이제일제당 (주) 싸이코스를 유효성분으로 하는 에쿠올 농도 상승제
JP5996187B2 (ja) * 2011-12-20 2016-09-21 株式会社ダイセル エクオールの製造方法
EP2832859B1 (en) * 2012-03-30 2018-07-25 Ajinomoto Co., Inc. Diabetes-inducible bacterium
CN104087532B (zh) * 2014-07-04 2016-04-20 浙江省农业科学院 一种来源于鸡肠道的雌马酚产生梭菌c1-6及应用
KR102064055B1 (ko) 2018-02-08 2020-01-08 신선옥 에쿠올이 생성된 발효커피생두, 그 제조방법 및 그 추출물
JP2018186823A (ja) * 2018-07-13 2018-11-29 株式会社ダイセル イソフラバノン類の製造方法
WO2020210194A1 (en) * 2019-04-08 2020-10-15 Corn Products Development, Inc. Improved plant-protein based analog dairy compositions
WO2020210547A1 (en) * 2019-04-09 2020-10-15 Martin Munzer Protein substitute amino acid compositions and products, and other food and beverage products
US11730778B2 (en) 2019-09-24 2023-08-22 Access Business Group International Llc Method of increasing the level and production of metabolized phytonutrients in a subject
KR20230013255A (ko) * 2020-05-21 2023-01-26 주식회사 다이셀 폐경 후에 갱년기 장애를 가지지 않는 만 40세 이상의 여성을 위한 qol 개선용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1656942A3 (en) * 1997-08-08 2008-02-27 Otsuka Pharmaceutical Co., Ltd. Isoflavone-containing composition
JP2006504409A (ja) * 2002-07-24 2006-02-09 チルドレンズ　ホスピタル　メディカル　センター 鏡像異性のエクオールを含有する組成物および製品、およびその製造方法
WO2004039327A2 (en) * 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
JP2003081855A (ja) 2002-08-19 2003-03-19 Yakult Honsha Co Ltd 脂質代謝改善剤およびそれを含有する食品
MXPA06000074A (es) * 2003-06-30 2006-03-21 Otsuka Pharma Co Ltd Composicion que contiene bacterias de acido lactico que producen equol.

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI491732B (zh) * 2005-12-06 2015-07-11 Otsuka Pharma Co Ltd 含雌馬酚（ｅｑｕｏｌ）之大豆胚軸發酵物及其製造方法
TWI491733B (zh) * 2005-12-06 2015-07-11 Otsuka Pharma Co Ltd 含雌馬酚（ｅｑｕｏｌ）之大豆胚軸發酵物及其製造方法（一）
TWI473572B (zh) * 2007-06-13 2015-02-21 大塚製藥股份有限公司 An extract containing equol (EQUOL), a method for producing the same, an equol extraction method and an equol-containing food

Also Published As

Publication number Publication date
US20190038684A1 (en) 2019-02-07
BRPI0412180A (pt) 2006-08-22
US10098915B2 (en) 2018-10-16
US20060148045A1 (en) 2006-07-06
CA2531173A1 (en) 2005-01-06
SI2548455T1 (sl) 2016-11-30
JP3864317B2 (ja) 2006-12-27
US8765445B2 (en) 2014-07-01
PT2548455T (pt) 2016-11-09
CY1118534T1 (el) 2017-07-12
EP1649760A1 (en) 2006-04-26
MY146563A (en) 2012-08-30
PL2548455T3 (pl) 2017-03-31
MXPA06000074A (es) 2006-03-21
CN1826059B (zh) 2011-09-28
AU2004251563B2 (en) 2009-04-23
CN1826059A (zh) 2006-08-30
AU2004251563A1 (en) 2005-01-06
DK2548455T3 (en) 2016-11-28
HK1090812A1 (en) 2007-01-05
WO2005000042A1 (ja) 2005-01-06
KR101043465B1 (ko) 2011-06-23
PL1649760T3 (pl) 2013-10-31
KR20110044810A (ko) 2011-04-29
BRPI0412180B1 (pt) 2014-06-17
EP2548455A1 (en) 2013-01-23
ES2601885T3 (es) 2017-02-16
JPWO2005000042A1 (ja) 2006-07-27
DK1649760T3 (da) 2013-07-08
EP1649760B1 (en) 2013-05-22
US20140050703A1 (en) 2014-02-20
SI1649760T1 (sl) 2013-07-31
AR044953A1 (es) 2005-10-12
TW201118175A (en) 2011-06-01
PT1649760E (pt) 2013-06-25
KR20060028436A (ko) 2006-03-29
SG157232A1 (en) 2009-12-29
CA2531173C (en) 2013-09-10
KR101054631B1 (ko) 2011-08-04
EP2548455B1 (en) 2016-08-31
EP1649760A4 (en) 2008-06-25
HUE030615T2 (en) 2017-05-29
CY1114248T1 (el) 2016-08-31
ES2417481T3 (es) 2013-08-08
TWI335353B (en) 2011-01-01

Similar Documents

Publication Publication Date Title
TW200510542A (en) Equol-producing lactic acid bacteria-containing composition
Blaut et al. Transformation of flavonoids by intestinal microorganisms
BR9916062A (pt) Administração oral de lactobacillus para o tratamento e prevenção de infecção urogenital
TW200732478A (en) Equol-containing fermentation product of soybean hypocotyl, and method for production thereof
MY127895A (en) New lactic acid bacteria strains capable of preventing diarrhoea
AU2002212986A1 (en) Beverage compositions comprising arabinogalactan and mineral supplement
WO2006008038A8 (de) Methyliden-d-xylopyranosyl- und oxo-d-xylopyranosyl-substituierte phenyle, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
WO2009125964A3 (en) Composition comprising polysaccharide extracted from panax ginseng preventing and treating liver diseases
EP1046396A3 (en) Soy protein and plant sterol containing composition for the reduction of low density lipoprotein cholesterol concentration
WO2006103401A3 (en) N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
PL374191A1 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
PL368976A1 (en) Composition for lowering blood cholesterol
SE9502588L (sv) Hämning av tillväxten av bakterier i samband med absorberande alster med hjälp av tillsats av andra bakterier
HK1043052A1 (en) Epigallocatechin-gallate for inhibiting angiogenesis
MX2009003202A (es) Tratamiento de jugos, extractos y pigmentos de plantas.
WO2011023830A3 (en) Anti-bacterial compositions comprising extracts of eremophila longifolia and methods for use of same
EP1669080A4 (en) METHOD FOR INHIBITING ALVEOLARY RESORPTION AND PERIODENTAL MEMBRANE LOSS AND COMPOSITION FOR INNER APPLICATION THEREOF
EP1663154A4 (en) EXTRACT OF MAHONIA AQUIFOLIUM / I, EXTRACTION METHOD AND PHARMACEUTICAL COMPOSITION CONTAINING SAID EXTRACT
WO2009047788A3 (en) Topical composition containing the combination of mupirocin and beclomethasone
BR0012973B1 (pt) Uso de bactéria do ácido láctico pertencente ao gênero Bifidobacterium, e composição alimentícia ou farmacêutica.
WO2002100327A3 (en) Substituted 1-benzazepines and derivatives thereof
TW200740469A (en) Orally disintegrating powder comprising cilostazol
WO2011068415A3 (en) Methods and feed compositions for masking of fish semiochemicals
AU2003301757A1 (en) Peroral preparation for prevention of or treatment for atopic dermatitis
EP1303300A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees